Search Results

You are looking at 1 - 10 of 785 items for :

  • "prevention" x
  • Refine by Access: All x
Clear All
Full access

Lindsey Robert Baden, William Bensinger, Michael Angarone, Corey Casper, Erik R. Dubberke, Alison G. Freifeld, Ramiro Garzon, John N. Greene, John P. Greer, James I. Ito, Judith E. Karp, Daniel R. Kaul, Earl King, Emily Mackler, Kieren A. Marr, Jose G. Montoya, Ashley Morris-Engemann, Peter G. Pappas, Ken Rolston, Brahm Segal, Susan K. Seo, Sankar Swaminathan, Maoko Naganuma, and Dorothy A. Shead

). The major categories of immunologic deficits in persons with cancer and the major pathogens to which they are susceptible are characterized. Specific guidelines are provided on the prevention, diagnosis, and treatment of the major common and

Full access

Crystal S. Denlinger, Jennifer A. Ligibel, Madhuri Are, K. Scott Baker, Wendy Demark-Wahnefried, Don Dizon, Debra L. Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H. Ku, Elizabeth Kvale, Terry S. Langbaum, Kristin Leonardi-Warren, Mary S. McCabe, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Mary Ann Morgan, Javid J. Moslehi, Tracey O’Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, Muhammad Raza, M. Alma Rodriguez, Karen L. Syrjala, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass

organism given in the vaccine. Risk Assessment and Screening for Immunizations and Prevention of Infections Survivors are at elevated risk for infections if their cancer treatment included chemotherapy, monoclonal antibodies, radiation

Full access

Amro Elshoury, Jordan K. Schaefer, Ming Y. Lim, Deidre P. Skalla, and Michael B. Streiff

Clinical Practice Guidelines in Oncology (NCCN Guidelines) for CAT primary prophylaxis guidelines, 6 with a primarily focus on VTE prevention. We also address 2 main clinical questions that providers usually encounter: (1) which patient with cancer should

Full access

Lindsey Robert Baden, Sankar Swaminathan, Michael Angarone, Gayle Blouin, Bernard C. Camins, Corey Casper, Brenda Cooper, Erik R. Dubberke, Ashley Morris Engemann, Alison G. Freifeld, John N. Greene, James I. Ito, Daniel R. Kaul, Mark E. Lustberg, Jose G. Montoya, Ken Rolston, Gowri Satyanarayana, Brahm Segal, Susan K. Seo, Shmuel Shoham, Randy Taplitz, Jeffrey Topal, John W. Wilson, Karin G. Hoffmann, and Courtney Smith

Prevention and Treatment of Cancer-Related Infections discuss infections in neutropenic and immunocompromised non-neutropenic patients with cancer. In addition to corticosteroids and purine analogs, the increased use of monoclonal antibodies, proteasome

Full access

William Bensinger, Mark Schubert, Kie-Kian Ang, David Brizel, Elizabeth Brown, June G. Eilers, Linda Elting, Bharat B. Mittal, Mark A. Schattner, Ricardo Spielberger, Nathaniel S. Treister, and Andy M. Trotti III

, and 12 hematologic and solid tumors. In this analysis, only 4 interventions for prevention showed any benefit: ice chips, antibiotic paste, amifostine, and hydrolytic enzymes. That review illustrates the limited number of wellresearched options for OM

Full access

Martin C. Mahoney

cancer risk: estrogen versus estrogen plus progestin . J Natl Cancer Inst 2000 ; 92 : 328 – 332 . 22. Fisher B Costantino JP Wickerham DL . Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel

Full access

David G. Hewett, Charles J. Kahi, and Douglas K. Rex

://www.medscape.com/cme/jnccn ; (4) view/print certificate. Learning Objectives Upon completion of this activity, participants will be able to: • Specify the effectiveness of other screening modalities in the prevention of colorectal cancer • Describe outcomes of research

Full access

Mamta Mehta and Moshe Shike

. 9 The evaluation of food and nutrition in the prevention of CRC, in particular, was updated in 2011. 10 Research on nutrition, however, is extremely challenging because dietary assessment techniques are imprecise in extracting data on consumption

Full access

Alok A. Khorana

Palumbo A Rajkumar SV Dimopoulos MA . Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma . Leukemia 2008 ; 22 : 414 - 423 . 29 Samama MM Cohen AT Darmon JY . A comparison of enoxaparin with placebo for the prevention of

Full access

Rudolph M. Navari

its use in the prevention of chemotherapy-induced nausea and vomiting . Drugs 2000 ; 59 : 1297 – 1315 . 18. Kimura E Niimi S Watanabe A . [Study on clinical effect of a continuous intravenous infusion of azasetron against nausea and